3230 Results

People

  1. Schoder
    Schoder
  2. Larson
    Larson
  3. Pandit-Taskar
    Pandit-Taskar
  4. Humm
    Humm
  5. Vargas Alvarez
    Vargas Alvarez
  6. Bodei
    Bodei
  7. Finn
    Finn
  8. Weber
    Weber
  9. Zanzonico
    Zanzonico
  10. Strauss
    Strauss

Groups

  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)
  7. Sloan Kettering Institute Postdocs (864)
  8. Body Imaging Service (649)
  9. Solid Tumor Oncology Division (647)
  10. Medical Physics (628)
  1. "Molecular Imaging and Therapy Service"
Formats
  1. Journal Article (1812)
  2. Meeting Abstract (932)
  3. Book Section (169)
  4. Review (156)
  5. Editorial (44)
  6. Conference Paper (40)
  7. Guidelines (31)
  8. Miscellaneous (18)
  9. Correspondence (12)
  10. Research Letter (11)
  11. Book Whole (5)
Groups
  1. Molecular Imaging and Therapy Service (3230)
  2. Radiology, Department of (3052)
  3. GSK Faculty (1475)
  4. Sloan Kettering Institute Faculty (1241)
  5. Molecular Pharmacology and Chemistry Program Faculty (1226)
  6. Department of Medicine (983)

More Groups

People
  1. Steven Larson (957)
  2. Heiko Schoder (543)
  3. Neeta Pandit-Taskar (342)
  4. John Humm (281)
  5. Hebert Vargas Alvarez (267)
  6. Lisa Bodei (205)

More People

Years
  1. 2025 (40)
  2. 2024 (129)
  3. 2023 (176)
  4. 2022 (175)
  5. 2021 (197)
  6. 2020 (195)

More Years

Publications
  1. Journal of Nuclear Medicine (569)
  2. Journal of Clinical Oncology (248)
  3. European Journal of Nuclear Medicine and Molecular Imaging (130)
  4. Blood (97)
  5. International Journal of Radiation Oncology, Biology, Physics (73)
  6. Clinical Nuclear Medicine (72)

More Publications

Publishers
  1. Society of Nuclear Medicine (569)
  2. Springer (430)
  3. Elsevier Inc. (303)
  4. American Society of Clinical Oncology (259)
  5. Lippincott Williams & Wilkins (154)
  6. American Association for Cancer Research (150)

More Publishers

Results (3230)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Diagnostic performance of PET/CT utilizing (68)Ga-DOTATATE, (18)F-FDG, (18)F-DOPA, and (18)F-FDA, and anatomic imaging in the detection of sporadic primary pheochromocytoma: A comparative prospective study
    Meeting Abstract

    Jha, A.; Ling, A.; Millo, C.; Chen, C.; Gonzales, M.; Patel, M.; Tena, I.; Mamilla, D.; Knue, M.; O'Sullivan Coyne, G.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Immuno-PET imaging of activation markers on antigen-specific CD4 T cells in a mouse model of melanoma
    Meeting Abstract

    Krebs, S.; Carter, L.; Hirschhorn-Cymerman, D.; Wolchok, J.; Merghoub, T.; Schoder, H.; Larson, S.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Personalized dosimetry using (131)I-anti-CD45-apamistamab (Iomab-B) prior to high-dose myeloablative radioimmunotherapy for hematopoietic stem cell transplant (HCT) in active, relapsed, or refractory acute myelogenous leukemia: Novel re-induction and targeted conditioning feasibility and engraftment results from the SIERRA trial
    Meeting Abstract

    Griffeth, L.; Passalaqua, S.; Wiseman, G.; Avril, N.; Yap, W.; Chen, M. K.; Wagner, R.; Natwa, M.; Chasen, B.; Lamonica, D.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • F-18 FDG PET/CT for monitoring immunotherapy with PD-1 blockade in patients with advanced melanoma
    Meeting Abstract

    Ito, K.; Nakajima, R.; Michaud, L.; Weber, W.; Schoder, H.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Prognostic value of metabolic parameters on pretreatment F-18 FDG PET/CT in patients with advanced melanoma treated with pembrolizumab
    Meeting Abstract

    Ito, K.; Michaud, L.; Nakajima, R.; Weber, W.; Schoder, H.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • (89)Zr-immuno-PET: Towards a non-invasive clinical tool to measure target engagement of therapeutic antibodies in-vivo
    Meeting Abstract

    Jauw, Y.; O'Donoghue, J.; Zijlstra, J.; Hoekstra, O.; Menke-van der Houven van Oordt, C.; Morschhauser, F.; Carrasquillo, J.; Zweegman, S.; Pandit-Taskar, N.; Lammertsma, A.; more...
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Initial experience with (18)F-flouroglutamine PET/CT imaging in brain tumor response assessment
    Meeting Abstract

    Goel, R.; Domfe, K.; Miller, A.; Krebs, S.; Young, R.; Grommes, C.; Tabar, V.; Dunphy, M.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Safety and effectiveness of (18)F-fluciclovine PET in adults with recurrent glioma: A retrospective observational study
    Meeting Abstract

    Bach-Gansmo, T.; Michaud, L.; Parent, E.; Akintayo, A.; Stevens, D.; Chau, A.; Dunphy, M.; Blasberg, R.; Schuster, D.; Goodman, M.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • 18F-rhPSMA-7 positron emission tomography (PET) for the detection of biochemical recurrence of prostate cancer following radical prostatectomy
    Meeting Abstract

    Eiber, M.; Kroenke, M.; Wurzer, A.; Ulbrich, L.; Jooay, L.; Maurer, T.; Kropf, S.; Horn, T.; Wester, H.; Weber, W.
    Journal of Nuclear Medicine (2019)

    Fulltext@MSK | Save
  • Pharmacokinetics and biodistribution of a [(86)Zr]Zr-DFO-MSTP2109A anti-STEAP1 antibody in metastatic castration-resistant prostate cancer patients
    Journal Article

    O'Donoghue, J. A.; Danila, D. C.; Pandit-Taskar, N.; Beylergil, V.; Cheal, S. M.; Fleming, S. E.; Fox, J. J.; Ruan, S.; Zanzonico, P. B.; Ragupathi, G.; more...
    Molecular Pharmaceutics (2019)

    Fulltext@MSK | Save